Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

44.00 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 306
Open 44.00
Bid (Size) 41.50 (6)
Ask (Size) 44.49 (1)
Prev. Close 44.00
Today's Range 44.00 - 44.00
52wk Range 41.08 - 100.77
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including 
Via MarketBeat
Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns
Jefferies Financial Group sees these three companies as prime candidates among stocks for double-digit returns. 
Via InvestorPlace

Performance

YTD
-40.36%
-40.36%
1 Month
-17.79%
-17.79%
3 Month
-29.03%
-29.03%
6 Month
-38.40%
-38.40%
1 Year
-50.99%
-50.99%

More News

Read More
Is It Time to Buy May's Worst-Performing Nasdaq Stocks?
Via The Motley Fool
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
Via Benzinga
How Is The Market Feeling About Exact Sciences?
Via Benzinga
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
Via Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Month
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Exact Sciences to Participate in June Investor Conferences
From Exact Sciences Corp.
Via Business Wire
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
Via InvestorPlace
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
Via Investor's Business Daily
Exposures Product Safety
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Earns 2024 Great Place To Work® Certification™
From Exact Sciences Corp.
Via Business Wire
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
From Exact Sciences Corp.
Via Business Wire
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level
Via Benzinga
Topics Stocks
Exposures US Equities
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
EXAS Stock Earnings: Exact Sciences Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.